<?xml version="1.0" encoding="UTF-8"?>
<p>If HCV treatment programs are rolled out in the future, they could also be well incorporated into existing ART and MMT infrastructure. Targeting coinfected patients for co-treatment is effective for both treatment and prevention, especially if the patients are enrolled in MMT. Costs may be difficult to control, but building programs into existing clinics and satellite centers may help curb short-term costs for long-term gains.</p>
